Open Access

EDITORIAL

Leonard G. Gomella
Canadian Journal of Urology, Vol.29, No.2, pp. 11040-11041, 2022
Abstract This article has no abstract. More >

View

34

Download

34

Open Access

LEGENDS IN UROLOGY

Remigio Vela Navarrete
Canadian Journal of Urology, Vol.29, No.2, pp. 11042-11044, 2022
Abstract This article has no abstract. More >

View

30

Download

32

Open Access

BOOK REVIEW

James Malone-Lee
Canadian Journal of Urology, Vol.29, No.2, pp. 11045-11045, 2022
Abstract This article has no abstract. More >

View

25

Download

31

Open Access

ARTICLE

Kathleen Olson, Rohan Vaidya, Aqsa Khan
Canadian Journal of Urology, Vol.29, No.2, pp. 11046-11051, 2022
Abstract Introduction: Urethral diverticulum in a male is a rare entity and the literature is limited to case reports and small case series. The aim of our study is to characterize this disease in patients from three Mayo Clinic locations.
Materials and methods: Chart analysis was performed of patients across all three Mayo Clinic sites that had International Classification of Diseases (ICD) codes corresponding to urethral diverticulum or urethral diverticulectomy via CPT code. Data were available for patients that were seen from 6/1/2003 through 10/5/2018. Patients were classified by age, etiology, presenting symptomatology, location, treatment, pathology, and postoperative outcomes.
… More >

View

29

Download

35

Open Access

ARTICLE

Jessica C. Dai¹, Tara N. Morgan¹, Alaina Garbens¹, Samuel Kusin², Hersh Trivedi², Claus G. Roehrborn¹, Jeffrey C. Gahan¹
Canadian Journal of Urology, Vol.29, No.2, pp. 11052-11058, 2022
Abstract Introduction: Anticholinergic or ß-3 agonist use following robotic simple prostatectomy (RASP) is not well described. We describe rates of antispasmodic use following RASP and identify potential predictors of medication use.
Materials and methods: A retrospective review of all RASP patients from 2/2016 - 1/2020 was conducted. Patients with no preoperative International Prostate Symptom Score (IPSS) were excluded. Demographics, clinical data, and postoperative medication use were collected by electronic medical record review. Multivariable logistic regression analysis using a priori variables was performed to identify independent factors associated with antispasmodic use.
Results: A total of 255 patients underwent RASP at… More >

View

22

Download

34

Open Access

ARTICLE

Facundo Davaro¹, David Weinstein¹, Ryan Wong¹, Sameer Siddiqui¹, Leslie Hinyard², Zachary Hamilton¹
Canadian Journal of Urology, Vol.29, No.2, pp. 11059-11066, 2022
Abstract Introduction: Management of prostate cancer has seen an increasing predilection for active surveillance in low risk (LR) patients. We aimed to evaluate the rate of pathologic upgrading in patients with very low (VLR) or LR prostate cancer after prostatectomy.
Materials and methods: The National Cancer Database (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) Database were queried for patients diagnosed with Gleason 6 prostate cancer and prostate specific antigen (PSA) < 10 ng/mL from 2010 to 2016. All patients underwent 12-core biopsy and a subsequent prostatectomy for final pathologic staging. Our primary outcome was rate of… More >

View

30

Download

39

Open Access

ARTICLE

Gopal Narang, Jonathan Moore, Haidar Abdul-Muhsin, Scott Cheney, Mitchell Humphreys
Canadian Journal of Urology, Vol.29, No.2, pp. 11067-11074, 2022
Abstract Introduction: Holmium laser enucleation of the prostate (HoLEP) is an effective but underutilized option for the surgical management of benign prostatic hyperplasia (BPH). With low adoption, questions arise surrounding patients access to care. It is unclear whether patients undergoing HoLEP are local or specifically seek care from afar. We looked to determine the proportion of patients who traveled out-of-state for HoLEP treatment and the impact of travel on peri and postoperative metrics.
Materials and methods: We performed a retrospective cohort study evaluating patients that underwent HoLEP at a single institution from 2007-2019. Patient demographic, perioperative data, postoperative… More >

View

25

Download

35

Open Access

ARTICLE

Dean S. Elterman¹, Naeem Bhojani², Christopher Vannabouathong¹, Bilal Chughtai³, Kevin C. Zorn²
Canadian Journal of Urology, Vol.29, No.2, pp. 11075-11079, 2022
Abstract Introduction: This analysis reported outcomes of treating catheter-dependent urinary retention with Rezum water vapor therapy.
Materials and methods: A prospective registry was established at two high-volume Canadian centers. Patients had baseline medical and benign prostatic hyperplasia (BPH) history documented. The subgroup of patients with refractory, catheter-dependent urinary retention was analyzed. The primary outcome was the proportion of patients who were spontaneously voiding and catheter-free at 6 months.
Results: Sixteen patients (age: 68.7 years) with catheter-dependent urinary retention were treated with Rezum. Average prostate volume was 84.4 mL and 75% had median lobe. All patients had at least one… More >

View

27

Download

33

Open Access

ARTICLE

Kristian D. Stensland^1,2, Joan C. Delto³, Navneet Ramesh⁴, Chris Robertson⁴, Jared P. Schober¹, Peter Chang⁵, Andrew A. Wagner⁵
Canadian Journal of Urology, Vol.29, No.2, pp. 11080-11086, 2022
Abstract Introduction: To assess the association between postoperative discharge day after minimally invasive partial nephrectomy with 30-day readmission rates, and specifically compare postoperative day 1 to postoperative day 2 discharge. We hypothesized that discharge on earlier postoperative days would be associated with higher rates of readmission after partial nephrectomy.
Materials and methods: The National Cancer Database was queried for patients undergoing minimally invasive partial nephrectomy for non-metastatic disease without chemo or radiation therapy from 2010-2014. Readmission rates were compared between postoperative discharge days. Multivariable logistic regression was used to analyze variables associated with 30-day readmission.
Results: A total of… More >

View

24

Download

31

Open Access

ARTICLE

Seth L. Teplitsky¹, Patrick J. Hensley¹, Amber Bettis², Andrew James¹, Andrew M. Harris^1,3
Canadian Journal of Urology, Vol.29, No.2, pp. 11087-11097, 2022
Abstract Introduction: To elucidate the association between operative duration (OD) and postoperative complications, which has been poorly studied in radical cystectomy. We hypothesize an increase in morbidity in radical cystectomy cases which have a longer OD.
Materials and methods: Data from the National Surgical Quality Improvement Program (NSQIP) between the years 2012 and 2018 were reviewed for radical cystectomy with ileal conduit urinary diversion or continent diversion. Total operative time was divided into deciles and stratified comparisons were made using univariable and multivariable analysis.
Results: A total of 11,128 patients were examined. OD by minutes was stratified into the… More >

View

27

Download

36

Open Access

ARTICLE

Marco Frisenda^1,2,*, Stefano Signore¹, Giampaolo Delicato¹, Andrea Giovanni Martinelli¹, Andrea Cantiani¹, Marco Colafelice³, Antonio Tufano², Francesco Del Giudice², Michael L. Eisenberg⁴, Alessandro Sciarra², Vittorio Canale^1,2,*
Canadian Journal of Urology, Vol.29, No.2, pp. 11095-11100, 2022
Abstract This article has no abstract. More >

View

25

Download

34

Open Access

ARTICLE

Joon Yau Leong¹, Joseph Schultz¹, Tingting Zhan², Joshua A. Marks³, Paul H. Chung^1，*
Canadian Journal of Urology, Vol.29, No.2, pp. 11101-11110, 2022
Abstract Introduction: Utilizing a physician-reported survey, we assessed general surgeons (GS) comfort level in the management of bladder trauma, from a GS and urologist’s perspective.
Materials and methods: Online questionnaires were distributed electronically to physicians of the American College of Surgeons and American Urological Association. This survey queried demographic data, clinical factors that may influence urology consultations, and bladder injury scenarios of varying severities. Two questions were presented for each scenario, the first querying GS comfort level in bladder trauma management, the second assessing the likelihood of obtaining urology consultations in such scenarios. Responses were graded on a… More >

View

27

Download

33

Open Access

HOW I DO IT

Brian T. Helfand¹, Ali Kasraeian², Steve Sterious³, Alexander P. Glaser¹, Pooja Talaty¹, Miguel Alcantara², Kaitlyn Mola Alcantara², Andrew Higgins³, Eric Ghiraldi³, Dean S. Elterman⁴
Canadian Journal of Urology, Vol.29, No.2, pp. 11111-11115, 2022
Abstract Aquablation has been well-studied in prostates sizes up to 150 mL. Recently, American Urological Association guidelines distinguish surgical interventions for men with large prostates (80 mL-150 mL) and now very large prostates (> 150 mL). Readers will gain an understanding of how to use Aquablation in the very large prostate size category. More >

View

22

Download

37

Open Access

RESIDENT’S CORNER

Lauren S. Faber¹, Julie M. Riley²
Canadian Journal of Urology, Vol.29, No.2, pp. 11116-11118, 2022
Abstract Eagle-Barrett Syndrome (EBS) is a rare congenital condition characterized by the triad of absent or defective abdominal wall muscles, urinary tract abnormalities, and bilateral cryptorchidism. Ureteropelvic junction obstruction (UPJO) is seldom reported in these patients, despite it being a common cause of childhood obstructive uropathy. We present the case of a patient with EBS who was subsequently identified as having symptomatic UPJO that was successfully treated with robotic pyeloplasty. More >

View

24

Download

27

Open Access

RESIDENT’S CORNER

Bryce A. Baird¹, Timothy D. Lyon¹, Kevin Wu², Augustus Anderson³, Gregory A. Broderick¹
Canadian Journal of Urology, Vol.29, No.2, pp. 11119-11122, 2022
Abstract Primary urethral carcinoma is a rare oncologic condition with limited data to support organ-sparing therapies. Herein, we present a case of primary urethral squamous cell carcinoma in situ of the bulbar urethra treated with intraurethral 5-fluorouracil (5-FU) who exhibited a complete pathologic response observed at the time of dismembered urethroplasty. The clinical features, diagnosis, and treatment course of our case are reviewed. These data may support the use of intraurethral 5-FU for similar cases in the future. More >

View

25

Download

36